Tham khảo Estradiol acetate

↑ https://www.drugs.com/cdi/estradiol-acetate.html
1 2 3 Sivanandy MS, Masimasi N, Thacker HL (tháng 5 năm 2007). “Newer hormonal therapies: lower doses; oral, transdermal, and vaginal formulations”. Cleveland Clinic Journal of Medicine. 74 (5): 369–75. doi:10.3949/ccjm.74.5.369. PMID 17506242.
1 2 3 4 5 6 7 https://www.drugs.com/international/estradiol-acetate.html
↑ Buckler H, Al-Azzawi F (2003). “The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women”. BJOG. 110 (8): 753–9. doi:10.1016/s1470-0328(03)02908-2. PMID 12892687.
1 2 3 https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021633s005lbl.pdf
1 2 3 4 “FEMRING”. DailyMed. U.S. National Library of Medicine.
1 2 Amit K. Ghosh (23 tháng 9 năm 2010). Mayo Clinic Internal Medicine Board Review. OUP USA. tr. 222–. ISBN 978-0-19-975569-1.
1 2 3 4 Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
1 2 3 Michael Oettel; Ekkehard Schillinger (6 tháng 12 năm 2012). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen. Springer Science & Business Media. tr. 261. ISBN 978-3-642-60107-1. Natural estrogens considered here include: [...] Esters of 17β-estradiol, such as estradiol valerate, estradiol benzoate and estradiol cypionate. Esterification aims at either better absorption after oral administration or a sustained release from the depot after intramuscular administration. During absorption, the esters are cleaved by endogenous esterases and the pharmacologically active 17β-estradiol is released; therefore, the esters are considered as natural estrogens.
1 2 Cirigliano M (tháng 6 năm 2007). “Bioidentical hormone therapy: a review of the evidence”. J Womens Health (Larchmt). 16 (5): 600–31. doi:10.1089/jwh.2006.0311. PMID 17627398.
1 2 3 Ballagh SA (2004). “Vaginal rings for menopausal symptom relief”. Drugs Aging. 21 (12): 757–66. doi:10.2165/00002512-200421120-00001. PMID 15382956.
1 2 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021633
1 2 Speroff L (tháng 10 năm 2003). “Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms”. Obstetrics and Gynecology. 102 (4): 823–34. doi:10.1016/s0029-7844(03)00764-6. PMID 14551014.
↑ Al-Azzawi F, Lees B, Thompson J, Stevenson JC (2005). “Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate”. Menopause. 12 (3): 331–9. doi:10.1097/01.gme.0000163870.03388.4d. PMID 15879923.
↑ Utian WH, Speroff L, Ellman H, Dart C (2005). “Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms”. Menopause. 12 (6): 708–15. doi:10.1097/01.gme.0000184220.63459.a8. PMID 16278614.
↑ Speroff L, Haney AF, Gilbert RD, Ellman H (2006). “Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms”. Menopause. 13 (3): 442–50. doi:10.1097/01.gme.0000182802.06762.b2. PMID 16735941.
↑ Deitra Leonard Lowdermilk; Shannon E. Perry; Mary Catherine Cashion; Kathryn Rhodes Alden (18 tháng 12 năm 2014). Maternity and Women's Health Care - E-Book. Elsevier Health Sciences. tr. 137–. ISBN 978-0-323-39019-4.
1 2 Lauritzen C (tháng 9 năm 1990). “Clinical use of oestrogens and progestogens”. Maturitas. 12 (3): 199–214. doi:10.1016/0378-5122(90)90004-P. PMID 2215269.
↑ Christian Lauritzen; John W. W. Studd (22 tháng 6 năm 2005). Current Management of the Menopause. CRC Press. tr. 95–98, 488. ISBN 978-0-203-48612-2.
↑ Laurtizen, Christian (2001). “Hormone Substitution Before, During and After Menopause” (PDF). Trong Fisch, Franz H. (biên tập). Menopause – Andropause: Hormone Replacement Therapy Through the Ages. Krause & Pachernegg: Gablitz. tr. 67–88. ISBN 978-3-901299-34-6.
↑ Midwinter, Audrey (1976). “Contraindications to estrogen therapy and management of the menopausal syndrome in these cases”. Trong Campbell, Stuart (biên tập). The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by the Institute of Obstetrics and Gynaecology, The University of London. MTP Press Limited. tr. 377–382. doi:10.1007/978-94-011-6165-7_33. ISBN 978-94-011-6167-1.
↑ Cheng ZN, Shu Y, Liu ZQ, Wang LS, Ou-Yang DS, Zhou HH (tháng 2 năm 2001). “Role of cytochrome P450 in estradiol metabolism in vitro”. Acta Pharmacol. Sin. 22 (2): 148–54. PMID 11741520.
↑ Düsterberg B, Nishino Y (tháng 12 năm 1982). “Pharmacokinetic and pharmacological features of oestradiol valerate”. Maturitas. 4 (4): 315–24. doi:10.1016/0378-5122(82)90064-0. PMID 7169965.
↑ U.S. Food and Drug Administration (2009). Menopause - Medicines to Help You. GPO FCIC. tr. 3–. ISBN 978-1-61221-026-1.
↑ Marc A. Fritz; Leon Speroff (28 tháng 3 năm 2012). Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. tr. 757–. ISBN 978-1-4511-4847-3.